
--- Page 1 ---
4073B-A147-4E07-B3F2 A8LC-01A-PR Redac ted TCD-o-3 Corewono, pepilleey reno 8Q4D|3 aese SPECIMENS: A. RIGHT RENAL TUMOR BASE Stc R3idreyNsS Cb4.9 B. RIGHT KIDNEY TUMOR hJ i/24)13 SPECIMEN(S): A. RIGHT RENAL TUMOR BASE B. RIGHT KIDNEY TUMOR INTRAOPERATIVE CONSULTATION DIAGNOSIS: FSA-right renal tumor base: No malignancy identified. Diagnosis called by Dr. to Dr. at DIAGNOSIS: A. KIDNEY, RIGHT, TUMOR BASE, EXCISION: - NEGATIVE FOR CARCINOMA B. KIDNEY, RIGHT, PARTIAL NEPHRECTOMY: - PAPILLARY RENAL CELL CARCINOMA, TYPE 2 - TUMOR SIZE: 2.5 CM IN GREATEST DIMENSION - SURGICAL RESECTION MARGIN IS INVOLVED BY CARCINOMA - SEE SYNOPTIC REPORT COMMENT; The surface inked orange is not real margin as per conversation with Dr. on SYNOPTIC REPORT - KIDNEY (PARTIAL OR RADICAL) Specimens Involved Specimens: A: RIGHT RENAL TUMOR BASE B: RIGHT KIDNEY TUMOR Specimen Type: Partial nephrectomy Without adrenal gland Laterality: Right Tumor Site: Not specified Focality: Unifocal Tumor Size (largest tumor if multiple): Greatest dimension: 2.5cm Macroscopic Extent of Tumor: Tumor limited to kidney WHO CLASSIFICATION Papillary renal cell carcinoma 8260/3 Histologic Grade (Fuhrman Nuclear Grade): G2: Nuclei slightly irregular, approximately 15 u nucleoli evident Invasion of Vascular/Lymphatic: Absent Perinephric Tissue Invasion: Absent Margins: Margin(s) involved by invasive carcinoma Include: Renal parenchymal margin (partial nephrectomy only) Adrenal Gland: Not present Regional Lymph Nodes: None sampled Additional Findings:  None identified Pathological Staging (pTNM):  pT 1a N x M x Pathological staging is based on the AJCC Cancer Staging Manual, 7th Edition pMX: Cannot be assessed SUMMARY OF IMMUNOHISTOCHEMISTRY/SPECIAL STAINS Material: Block B2 Population: Tumor Cells Stain/Marker:Result:  Comment:

--- Page 2 ---
CYTOKERATIN 7 Positive CD 10 Positive Material: Block B5 Population: Tumor Cells Stain/Marker:Result:  Comment: RACEMACE Positive Carbonic Anhydrase IX  Positive Equivocal The interpretation of the above immunohistochemistry stain or stains is guided by published results in. the medical literature, provided package information from the manufacturer and by internal review of staining performance and assay validation within the. The use of one or more reagents in the above tests is regulated as an analyte specific reagent (ASR). These. tests were developed and their performance characteristic determined by the. They have not been cleared or approved by the U.S. Food and Drug Administration. The. FDA has determined that such clearance or approval is not necessary.. Special stains and/or immunohistochemical stains were performed with appropriately stained positive and/or negative controls. GROSS DESCRIPTION: A. RIGHT RENAL TUMOR BASE Received fresh labeled the patient's identification and "right renal tumor base" is a 0.3 x 0.2 x 0.1 cm piece of red-tan soft tissue; submitted in the frozen section diagnosis, FSA.. B. RIGHT KIDNEY TUMOR Received fresh labeled with the patient's identification and "right kidney tumor" is a 9 g, 3.7 x 2.5 x 1.3 cm piece of kidney with 1.3 x 0.5 x 0.5 cm piece of attached perinephric fat. The surface has a 1.5 x 1 cm defect. The specimen is oriented by Dr.. The true margin (surrounding the defect) is inked black and the remainder of the specimen is inked orange. On sectioning, there is a well-circumscribed mottled tan and brown nodule, 2.5 x 2.3 x 1.8 cm, which abuts the true margin. Photographs are taken and tissue is procured; submitted entirely, B1-B8. CLINICAL HISTORY: None Given PRE-OPERATIVE DIAGNOSIS: Right renal mass Gross Dictation:  Microscopic/Diagnostic Dictation: Final Review.., Pathologist Final: Pathologist.